Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for ACST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 50.07M
March 31, 2026 77.60M
December 31, 2025 68.49M
September 30, 2025 66.58M
June 30, 2025 69.80M
March 31, 2025 81.24M
December 31, 2024 61.22M
September 30, 2024 65.35M
June 30, 2024 69.72M
March 31, 2024 73.30M
December 31, 2023 76.18M
September 30, 2023 78.21M
June 30, 2023 73.03M
March 31, 2023 79.12M
December 31, 2022 116.80M
September 30, 2022 120.91M
June 30, 2022 124.93M
March 31, 2022 128.62M
December 31, 2021 114.23M
September 30, 2021 119.80M
June 30, 2021 60.45M
March 31, 2021 62.46M
December 31, 2020 30.30M
September 30, 2020 13.83M
June 30, 2020 20.14M
Date Value
December 31, 2019 29.98M
September 30, 2019 28.58M
June 30, 2019 29.49M
March 31, 2019 36.28M
December 31, 2018 43.68M
September 30, 2018 15.41M
June 30, 2018 20.46M
March 31, 2018 17.81M
December 31, 2017 21.89M
September 30, 2017 15.80M
June 30, 2017 17.35M
November 30, 2016 16.06M
August 31, 2016 17.95M
May 31, 2016 19.68M
February 29, 2016 21.05M
November 30, 2015 23.23M
August 31, 2015 24.82M
May 31, 2015 28.17M
February 28, 2015 29.80M
November 30, 2014 34.21M
August 31, 2014 38.13M
May 31, 2014 40.36M
February 28, 2014 41.22M
November 30, 2013 24.09M
August 31, 2013 24.53M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
AbbVie, Inc. 135.12B
Abeona Therapeutics, Inc. 179.51M
America Great Health 0.1671M
Acumen Pharmaceuticals, Inc. 116.01M
Aardvark Therapeutics, Inc. 81.46M

Total Assets (Quarterly) Related Metrics